Serum-free culture conditions for the generation of dendritic cells from cord blood CD34+ hematopoietic progenitors: phenotypic and functional analysis

Domènech Estévez, EnricVillén, EstherGonzález Barca, EvaQuerol Giner, SergiGarcía, JoanRueda, Fèlix, 1951-2020-12-142020-12-142000-09-010390-6078https://hdl.handle.net/2445/172717Increasing pre-clinical and clinical data suggest the efficiency of dendritic cells (DCs) in cancer immunotherapy. Relapse after cord blood hematopoietic progenitors (CBHP) transplantation is an unresolved problem. DCs obtained from CBHP could be an interesting tool for relapse treatments, but the low number of CBHP hinder their use for DC generation.2 p.application/pdfeng(c) Ferrata Storti Foundation, 2000AntígensCèl·lules dendrítiquesCitologiaImmunologiaAntigensDendritic cellsCytologyImmunologySerum-free culture conditions for the generation of dendritic cells from cord blood CD34+ hematopoietic progenitors: phenotypic and functional analysisinfo:eu-repo/semantics/article5974082020-12-14info:eu-repo/semantics/openAccess10980642